On July 6, BrightSpring Health Services rose 5.52% overnight, trading at $72.84/share, with turnover of $129,500.

On the news front, BofA Securities significantly raised its price target on BrightSpring Health Services to $77 from $66, maintaining a Buy rating. The new target stands well above the current analyst consensus mean price target of $58.47, signaling strong conviction in the company's growth trajectory. This upgrade follows a series of bullish revisions from major investment banks, including UBS raising its target to $55 and Deutsche Bank to $50 earlier this year.

The positive sentiment is underpinned by strong fundamentals. The company reported Q1 adjusted EPS of $0.39, beating the consensus estimate of $0.31 by approximately 26%, representing a 105% year-over-year increase. Full-year guidance was also raised. Additionally, the company announced a stock buyback program in June alongside a secondary offering, signaling management confidence in long-term value. The March completion of the ResCare Community Living divestiture further sharpened the company's strategic focus on pharmacy and provider services.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)